European Primary Care Cardiovascular Society
Preventing Cardiovascular Disease in Patients with T2DM - How to apply novel outcome data with GLP-1 RA to clinical practice (2/3)

Diabetes: How to reduce risk from a cardiovascular perspective?

July 12, 2018 - Prof. Diederick Grobbee - Utrecht, The Netherlands

Lipids and food

July 11, 2018 - Prof. David Marais - Cape Town, South Africa

The cardiovascular challenge for primary care in diabetes

July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Spain - EPCCS Introduction

June 19, 2018

Lower Extremity Artery Disease: a neglected major CV disease: Diagnosis and clinical management in primary care

Mar. 15, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Rafel Ramos (Girona, Spain)

Lipid lowering: the evidence, the guidelines, the clinical reality

Mar. 17, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Monika Hollander, prof. Frank Visseren, dr. Jan Oltrogge

Management of CV risk that comes with T2DM in light of novel treatment options

Mar. 15, 2018 - EPCCS 2018, Barcelona, Spain - Dr. Carlos Brotons, prof. Xavier Cos, prof. Richard Hobbs

Treatment of high-risk ACS patients may change based on ODYSSEY OUTCOMES study results

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Dr. Valentin Fuster, New York, NY, USA

Pharmacist intervention in American 'black barbershops' effective at lowering BP

Mar. 12, 2018 - ACC 2018, Orlando, FL, USA - Dr. Ronald Victor, MD - Los Angeles, CA, USA

PCSK9 inhibitor has very good benefit-to-risk profile in high risk ACS patients in ODYSSEY OUTCOMES trial

Mar. 10, 2018 - ACC 2018, Orlando, FL, USA - Prof. Gabriel Steg - Paris, France

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

Things to consider when aiming to prevent stroke in a patient with AF

May 25, 2017
##SCROLLER_ITEMS_FULL_TITLE##

What can be learned from the latest hypertension trials?

May 26, 2017
##SCROLLER_ITEMS_FULL_TITLE##

Heart failure diagnosis and management varies substantially across European countries

May 25, 2017

How do the latest guideline changes affect management of dyslipidaemia in primary care?

May 26, 2017
##SCROLLER_ITEMS_FULL_TITLE##

Ingredients of effective strategies to stimulate behaviour change

May 25, 2017

The evidence base for health behaviour changes

Dec. 9, 2015 - EPCCS 2015 - Prague, Czech Republic

Identifying and treating patients with true hypertension

Feb. 24, 2016 - Prague - EPCCS 2015

Diabetes: How to reduce risk from a cardiovascular perspective?

July 12, 2018 - Prof. Diederick Grobbee - Utrecht, The Netherlands
Prof. Grobbee discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents

Prof. Grobbee discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents

Lipids and food

July 11, 2018 - Prof. David Marais - Cape Town, South Africa
Prof. David Marais reviews the impact of various dietary lipids as they relate to the conventional lipoprotein profile in  persons who do not have significant metabolic defects, as well as the impact on persons with metabolic disease.

Prof. David Marais reviews the impact of various dietary lipids as they relate to the conventional lipoprotein profile in persons who do not have significant metabolic defects, as well as the impact on persons with metabolic disease.

Intensive BP treatment in T2DM patients on standard glycemic control associated with decreased CV risk

July 11, 2018 - Tsujimoto T and Kajio H. - Hypertension. 2018

In a subanalysis of the ACCORD BP trial, intensive blood pressure treatment in T2DM patients receiving standard glycemic control was significantly associated with a decreased risk of CV events, including HF hospitalization.

Inversed association between nut consumption and the risk on AF and HF

July 11, 2018 - Larsson SC, et al. - Heart 2018

A prospective study showed an inversed association between nut consumption and incidence of atrial fibrillation and heart failure in the Swedish population.

The cardiovascular challenge for primary care in diabetes

July 10, 2018 - Prof. Richard Hobbs - Oxford, UK
Prof. Hobbs stresses  the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Reduction of CVD with healthy lifestyle after diabetes diagnosis

July 3, 2018

Maintaining or changing to a healthy lifestyle after diabetes diagnosis is associated with a significantly lower risk CVD incidence and mortality.

PCSK9 inhibitor and statins highly effective in people with diabetes with ACS

June 25, 2018 - news

ADA 2018 Analysis of ODYSSEY OUTCOMES trial indicates people with diabetes and prior ACS benefit most from the combination of alirocumab and statins, compared to ACS survivors with prediabetes or with normal glucose levels

Clear health benefits with cost effective intense multifactorial treatment for T2DM

June 25, 2018 - news

ADA 2018 In long-term Danish Steno 2 study, interventions targeting complications were found to improve disease-free-life length, and costs were not higher than with conventional treatment.

Exaggerated BP response to exercise in hypertensives with controlled resting BP

June 20, 2018 - Chant B, et al. - Hypertension 2018

BP responses to exercise are similar in treated–controlled, treated-uncontrolled, and untreated hypertensives but higher compared with normotensives.

Risk of dementia increases with hypertension duration in mid-life

June 19, 2018 - Abell JG et al. - Eur Heart J 2018

Individuals with hypertension at mid-life, defined as SBP ≥130 mmHg at the age of 50, have an increased risk of dementia, which is proportional to the duration of the exposure to hypertension

New 2018 ESC/ESH Guidelines for treatment of hypertension - a first look

June 14, 2018 - news

Before publication later this year, a first look at the new 2018 ESC/ESH Guidelines of hypertension was presented. One of the key messages was the unchanged definition of hypertension of BP >140/90 mmHg.

High CV risk in obese women even in the absence of metabolic abnormalities

June 13, 2018 - Eckel N, et al. - Lancet Diab Endocrin 2018

CV risk is high in obese women without metabolic abnormalities, as well as in women with hypertension, diabetes or hypercholesterolemia, independently of their body mass index.